[{"id":"bdc6fc23-157c-455c-84b1-7f3ba467351f","acronym":"","url":"https://clinicaltrials.gov/study/NCT02983279","created_at":"2021-01-18T14:40:35.597Z","updated_at":"2024-07-02T16:35:58.100Z","phase":"","brief_title":"Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer","source_id_and_acronym":"NCT02983279","lead_sponsor":"Sidney Kimmel Cancer Center at Thomas Jefferson University","biomarkers":" MIR21","pipe":" | ","alterations":" miR-21 expression","tags":["MIR21"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e miR-21 expression"],"overall_status":"Completed","enrollment":" Enrollment 49","initiation":"Initiation: 09/20/2016","start_date":" 09/20/2016","primary_txt":" Primary completion: 10/27/2021","primary_completion_date":" 10/27/2021","study_txt":" Completion: 12/29/2022","study_completion_date":" 12/29/2022","last_update_posted":"2023-01-06"},{"id":"e042b558-d137-466c-b02c-21bbc895a34e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05151224","created_at":"2021-12-09T18:00:18.649Z","updated_at":"2024-07-02T16:36:19.667Z","phase":"","brief_title":"Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma","source_id_and_acronym":"NCT05151224","lead_sponsor":"Ain Shams University","biomarkers":" HER-2 • BCL2 • MIR21","pipe":" | ","alterations":" HER-2 positive • miR-21 expression","tags":["HER-2 • BCL2 • MIR21"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • miR-21 expression"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 40","initiation":"Initiation: 12/01/2021","start_date":" 12/01/2021","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 01/01/2024","study_completion_date":" 01/01/2024","last_update_posted":"2021-12-09"}]